Literature DB >> 22104116

Elevated levels of C-reactive protein as a risk factor for metabolic syndrome in Indians.

Anubha Mahajan1, Alok Jaiswal, Rubina Tabassum, Avijit Podder, Saurabh Ghosh, S V Madhu, Sandeep K Mathur, Nikhil Tandon, Dwaipayan Bharadwaj.   

Abstract

OBJECTIVE: Relationship of high sensitivity C-reactive protein (hsCRP) with metabolic syndrome (MetS) is well documented in many populations, but comprehensive data is lacking in Indian population. Thus, we set out to investigate the association of hsCRP levels with MetS and its features and the effect of obesity and insulin resistance on this association in urban Indians.
METHODS: This is a cross-sectional study that included 9517 subjects comprising 4066 subjects with MetS. MetS was defined according to the modified National Cholesterol Education Program (NCEP) Adult Treatment Panel (ATP III) criteria for Asians.
RESULTS: Median levels of hsCRP were considerably higher in individuals with MetS with higher levels in women compared to men. Among the features of MetS, waist circumference was most strongly correlated with hsCRP levels (r=0.28) and contributed maximally (β=0.025mg/l lnhsCRP, P=7.4×10(-147)). Subjects with high risk hsCRP levels (>3mg/l) were at high risk of MetS (OR (95% CI)=1.65(1.41-1.92), P=1.7×10(-10)). Risk of MetS increased in a dose dependent manner from low risk to high risk hsCRP category with increase in BMI and HOMA-IR.
CONCLUSIONS: Our findings suggest that hsCRP predicts the risk of MetS, independent of obesity and insulin resistance, and therefore, can be a valuable tool to aid the identification of individuals at risk of MetS. The study provides a lead for future investigation for effects of hsCRP, obesity, and insulin resistance on MetS in this population.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22104116     DOI: 10.1016/j.atherosclerosis.2011.10.031

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  17 in total

1.  Authors reply to Dr. Kawada's comments.

Authors:  Tsan Yang; Chien-An Sun
Journal:  Endocrine       Date:  2013-08-13       Impact factor: 3.633

2.  Arterial stiffness and influences of the metabolic syndrome: a cross-countries study.

Authors:  Angelo Scuteri; Pedro G Cunha; E Agabiti Rosei; Jolita Badariere; Sofie Bekaert; John R Cockcroft; Jorge Cotter; Francesco Cucca; Marc L De Buyzere; Tim De Meyer; Luigi Ferrucci; Osca Franco; Nichola Gale; Thierry C Gillebert; A Hofman; Michel Langlois; Aleksandras Laucevicius; Stephane Laurent; Francesco U S Mattace Raso; Cristopher H Morrell; Maria Lorenza Muiesan; Margaret M Munnery; Rokas Navickas; Pedro Oliveira; Marco Orru'; Maria Grazia Pilia; Ernst R Rietzschel; Ligita Ryliskyte; Massimo Salvetti; David Schlessinger; Nuno Sousa; Christodoulos Stefanadis; James Strait; Caroline Van Daele; Isabel Villa; Charalambos Vlachopoulos; Jacqueline Witteman; Panagiotis Xaplanteris; Peter Nilsson; Edward G Lakatta
Journal:  Atherosclerosis       Date:  2014-01-30       Impact factor: 5.162

3.  Serum C-reactive protein and metabolic components.

Authors:  Tomoyuki Kawada
Journal:  Endocrine       Date:  2013-04-26       Impact factor: 3.633

4.  Identification of microsatellite markers and their application in yellow catfish (Pseudobagrus fulvidraco Richardson, 1846) population genetics of Korea.

Authors:  Jeong-Nam Yu; Sang-Ki Kim; Jin Sagong; Shi Hyun Ryu; Byungsoo Chae
Journal:  J Genet       Date:  2019-03       Impact factor: 1.166

5.  Impact of glucocorticoid receptor gene (NR3C1) polymorphisms in Turkish patients with metabolic syndrome.

Authors:  Z Kaya; S Caglayan; M Akkiprik; C Aral; G Ozisik; M Ozata; A Ozer
Journal:  J Endocrinol Invest       Date:  2015-11-23       Impact factor: 4.256

6.  Gamma-glutamyl transferase and C-reactive protein as alternative markers of metabolic abnormalities and their associated comorbidites: a prospective cohort study.

Authors:  Jennifer C Melvin; Crystal Rodrigues; Lars Holmberg; Hans Garmo; Niklas Hammar; Ingmar Jungner; Göran Walldius; Mats Lambe; Wayel Jassem; Mieke Van Hemelrijck
Journal:  Int J Mol Epidemiol Genet       Date:  2012-11-15

Review 7.  Genetic epidemiology of coronary artery disease: an Asian Indian perspective.

Authors:  Shanker Jayashree; Maitra Arindam; Kakkar V Vijay
Journal:  J Genet       Date:  2015-09       Impact factor: 1.166

8.  High-sensitivity C-reactive protein to detect metabolic syndrome in a centrally obese population: a cross-sectional analysis.

Authors:  Corine den Engelsen; Paula S Koekkoek; Kees J Gorter; Maureen van den Donk; Philippe L Salomé; Guy E Rutten
Journal:  Cardiovasc Diabetol       Date:  2012-03-14       Impact factor: 9.951

9.  Variations of lipoprotein(a) levels in the metabolic syndrome: a report from the Maracaibo City Metabolic Syndrome Prevalence Study.

Authors:  Valmore Bermúdez; Joselyn Rojas; Juan Salazar; Luis Bello; Roberto Añez; Alexandra Toledo; Maricarmen Chacín; Miguel Aguirre; Marjorie Villalobos; Mervin Chávez; María Sofía Martínez; Wheeler Torres; Yaquelin Torres; José Mejías; Edgardo Mengual; Liliana Rojas; Milagro Sánchez de Rosales; Ana Quevedo; Raquel Cano; Mayela Cabrera; Rafael París; Adonías Lubo; María Montiel; Climaco Cano
Journal:  J Diabetes Res       Date:  2013-04-22       Impact factor: 4.011

10.  Association between leukocyte and metabolic syndrome in urban Han Chinese: a longitudinal cohort study.

Authors:  Wenjia Meng; Chengqi Zhang; Qian Zhang; Xinhong Song; Haiyan Lin; Dongzhi Zhang; Yongyuan Zhang; Zhenxin Zhu; Shuo Wu; Yanxun Liu; Fang Tang; Xiaowei Yang; Fuzhong Xue
Journal:  PLoS One       Date:  2012-11-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.